Brainsway Ltd. (BWAY): Price and Financial Metrics
GET POWR RATINGS... FREE!
BWAY Stock Price Chart Interactive Chart >
BWAY Price/Volume Stats
|Current price||$11.57||52-week high||$11.77|
|Prev. close||$11.62||52-week low||$5.52|
|Day high||$11.61||Avg. volume||76,960|
|50-day MA||$9.58||Dividend yield||N/A|
|200-day MA||$7.80||Market Cap||190.33M|
Brainsway Ltd. (BWAY) Company Bio
Brainsway Ltd. engages in the research, development and marketing of medical device for non-invasive treatment of the brain disorders. Its technology enables handling of a wide range of indications through the TMS Deep system developed by the company. Brainsway operates through the following segments: Major depression and Obsessive Compulsive Disorder (OCD). The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
BWAY Latest News Stream
|Loading, please wait...|
BWAY Latest Social Stream
View Full BWAY Social Stream
Latest BWAY News From Around the Web
Below are the latest news stories about Brainsway Ltd that investors may wish to consider to help them evaluate BWAY as an investment opportunity.
Brainsway (BWAY): Q1 GAAP EPS of -$0.11 misses by $0.03.Revenue of $6.1M (+46.6% Y/Y) beats by $0.29M.Press Release...
BrainsWay Ltd. (BWAY) Q1 2021 Earnings Conference Call May 20, 2021 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Chris von Jako - President & Chief Executive Officer Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann Kyle Mikson...
BWAY Price Returns